The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site.
AUTOR(ES)
Kjeldsen, T
RESUMO
To identify the region(s) of the insulin receptor and the insulin-like growth factor I (IGF-I) receptor responsible for ligand specificity (high-affinity binding), expression vectors encoding soluble chimeric insulin/IGF-I receptors were prepared. The chimeric receptors were expressed in mammalian cells and partially purified. Binding studies revealed that a construct comprising an IGF-I receptor in which the 68 N-terminal amino acids of the insulin receptor alpha-subunit had replaced the equivalent IGF-I receptor segment displayed a markedly increased affinity for insulin. In contrast, the corresponding IGF-I receptor sequence is not critical for high-affinity IGF-I binding. It is shown that part of the cysteine-rich domain determines IGF-I specificity. We have previously shown that exchanging exons 1, 2, and 3 of the insulin receptor with the corresponding IGF-I receptor sequence results in loss of high affinity for insulin and gain of high affinity for IGF-I. Consequently, it is suggested that the ligand specificities of the two receptors (i.e., the sequences that discriminate between insulin and IGF-I) reside in different regions of a binding site with common features present in both receptors.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=51668Documentos Relacionados
- Importance of receptor occupancy, concentration differences, and ligand exchange in the insulin-like growth factor I receptor system.
- Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
- The receptor for insulin-like growth factor II mediates an insulin-like response.
- Developmental regulation of the rat insulin-like growth factor I receptor gene.
- Bioactive Insulin-Like Growth Factor-I in Obesity